Literature DB >> 1948795

Microlavage: a technique for determining the volume of epithelial lining fluid.

D R Baldwin1, R Wise, J M Andrews, D Honeybourne.   

Abstract

A new technique ("microlavage") was used to determine the volume of epithelial lining fluid recovered by bronchoalveolar lavage. A standard bronchial brush tube is used to lavage a peripheral lung subsegment rapidly with 20 ml of normal saline and the concentrations of urea and total protein are measured in the aspirated fluid. Using a very short dwell time for fluid (less than 20 seconds), this technique allows the urea dilution method to be used to quantify the epithelial lining fluid protein concentration, which is then used as an endogenous marker of the epithelial lining fluid in conventional bronchoalveolar lavage fluid. The reproducibility of the calculation of the concentration of the lining fluid protein was assessed in 10 patients by performing the method in three separate lung subsegments. The mean coefficient of variation of the urea to protein ratio was 9.0%. A comparison of microlavage and conventional lavage was made in a further 28 patients. The differential cell counts were similar by the two methods, suggesting that similar epithelial lining fluid was sampled. The application of the microlavage technique to the calculation of epithelial lining fluid volume gave a lower value than the urea dilution method in association with conventional lavage. Microlavage should provide more accurate quantification of epithelial lining fluid volume and could be used in conjunction with conventional lavage, which is still required for an adequate harvest of alveolar cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1948795      PMCID: PMC463361          DOI: 10.1136/thx.46.9.658

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  PERMEABILITY OF THE ALVEOLAR MEMBRANE TO SOLUTES.

Authors:  A E TAYLOR; A C GUYTON; V S BISHOP
Journal:  Circ Res       Date:  1965-04       Impact factor: 17.367

2.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

3.  Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage.

Authors:  T W Marcy; W W Merrill; J A Rankin; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-06

4.  Movement of ions and small solutes across endothelium and epithelium of perfused rabbit lungs.

Authors:  R M Effros; G R Mason; P Silverman; E Reid; J Hukkanen
Journal:  J Appl Physiol (1985)       Date:  1986-01

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Quantitation of bronchoalveolar lavage with methylene blue.

Authors:  R P Baughman; C H Bosken; R G Loudon; P Hurtubise; T Wesseler
Journal:  Am Rev Respir Dis       Date:  1983-08

7.  Effect of bronchial lavage volume on cellular and protein recovery.

Authors:  S Lam; J C Leriche; K Kijek; D Phillips
Journal:  Chest       Date:  1985-12       Impact factor: 9.410

8.  Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers.

Authors:  R B Low; G S Davis; M S Giancola
Journal:  Am Rev Respir Dis       Date:  1978-11

9.  Kinetic analysis of respiratory tract proteins recovered during a sequential lavage protocol.

Authors:  W Merrill; E O'Hearn; J Rankin; G Naegel; R A Matthay; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1982-10

Review 10.  Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.

Authors:  R P Daniele; J A Elias; P E Epstein; M D Rossman
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

View more
  16 in total

1.  Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.

Authors:  J E Conte; J A Golden; M McQuitty; J Kipps; E T Lin; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 2.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 3.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

4.  Penetration of orally administered prulifloxacin into human lung tissue.

Authors:  Ercole Concia; Benedetta Allegranzi; Giovanni B Ciottoli; Giovanna Orticelli; Marcello Marchetti; Paolo Dionisio
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 5.  Bronchoalveolar lavage as a research tool.

Authors:  E H Walters; P V Gardiner
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

6.  Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation.

Authors:  Christopher M Rubino; Lei Ma; Sujata M Bhavnani; Joan Korth-Bradley; John Speth; Evelyn Ellis-Grosse; Keith R Rodvold; Paul G Ambrose; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

7.  Intrapulmonary pharmacokinetics of linezolid.

Authors:  John E Conte; Jeffrey A Golden; Juliana Kipps; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

8.  Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.

Authors:  John E Conte; Jeffrey A Golden; Mari McQuitty; Juliana Kipps; Sheila Duncan; Elaine McKenna; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.

Authors:  Mark H Gotfried; Jeng-Pyng Shaw; Bret M Benton; Kevin M Krause; Michael R Goldberg; Michael M Kitt; Steven L Barriere
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

10.  Adult and paediatric size bronchoscopes for bronchoalveolar lavage in mechanically ventilated patients: yield and side effects.

Authors:  B Ricou; S Grandin; L Nicod; J B Thorens; P M Suter
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.